The TGA are seeking applications for a number of remunerated advisory committee appointments from professionals with expertise in relevant medical or scientific fields or consumer health. Applications close 13 August 2021.

For complementary medicines, having relevant experts with a strong understanding of CM including nutritional medicines and traditional medicines in the Advisory Committee for Complementary Medicines can appropriately inform critical TGA decisions relating to Complementary Medicine regulation. Matters this Committee have advised on in the last 2 years include:

• Vitamin B6 (pyridoxine) with peripheral neuropathy and whether the current maximum daily dose for listed medicines (200 mg eqv. pyroxidine) is appropriate.

• The relationship between taste disturbance/loss-of-taste adverse events reported for products with Andrographis paniculata and associated restrictions for listed medicines.

• Whether listed medicines containing higher doses of various forms of magnesium should carry a label warning or have additional restrictions for potential laxative effects.

• Probiotics - characterisation for the purposes of establishing the quality and safety of applications relating to microorganisms.

• Probiotics - What constitutes adequate control of the composition, strength, stability and performance characteristics of a multi-strain probiotic.

• Valeriana officinalis to cause herb-induced liver injury, and whether there is a sufficient evidence to support restrictions to mitigate the risk when used in listed medicines.

• Aspects of clinical trial data that are critical to make publicly available as part of conducting a clinical trial the TGA's proposed data protection scheme for assessed listed medicines.

• Suitability of an herbal ingredient in listed medicines indicated for use during conception, pregnancy and lactation.

Please see today’s member alert for more information on how to apply.